Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system SEMINARS IN IMMUNOLOGY Brocke, S., Hausmann, S., Steinman, L., Wucherpfennig, K. W. 1998; 10 (1): 57-67

Abstract

The mechanisms by which microbial peptide antigens and superantigens might initiate and perpetuate autoimmune responses against antigens of the central nervous system are discussed. A model will be proposed that includes the initial activation of naive T lymphocytes through T cell receptor-mediated recognition of microbial antigens presented by MHC class II molecules. This event might be followed by re-activation of autoreactive T cells by bacterial and viral superantigens. Both mechanisms could lead to acute and relapsing autoimmune disease.

View details for Web of Science ID 000076581500007

View details for PubMedID 9529656